OncoMed Pharmaceuticals Inc Revenue
OncoMed Pharmaceuticals Inc reported Revenue of $6.87 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-08-02
- OncoMed Pharmaceuticals Inc revenues for the quarter ending 2018-06-30 was $6.87M, a 10.90% increase year-over-year.
- OncoMed Pharmaceuticals Inc revenues for the quarter ending 2018-03-31 was $7.85M, a 26.33% increase year-over-year.
- OncoMed Pharmaceuticals Inc revenues for the quarter ending 2017-12-31 was $20.64M, a 231.89% increase year-over-year.
- OncoMed Pharmaceuticals Inc revenues for the quarter ending 2017-09-30 was $5.11M, a 13.74% decline year-over-year.
- OncoMed Pharmaceuticals Inc revenues for fiscal 2017 was $38.15M, a 51.69% increase from fiscal 2016.
- OncoMed Pharmaceuticals Inc revenues for fiscal 2016 was $25.15M, a 2.88% decline from fiscal 2015.
- OncoMed Pharmaceuticals Inc revenues for fiscal 2015 was $25.90M, a 34.53% decline from fiscal 2014.
- OncoMed Pharmaceuticals Inc revenues for fiscal 2014 was $39.56M, a 4.71% increase from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-06-30 | $6.87M 10-Q · filed 2018-08-02 | $14.72M 10-Q · filed 2018-08-02 | $35.36M derived: sum of 3 quarters · filed 2018-08-02 | $40.47M derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | $7.85M 10-Q · filed 2018-05-08 | $28.49M derived: sum of 2 quarters · filed 2018-05-08 | $33.59M derived: sum of 3 quarters · filed 2018-05-08 | $39.79M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-12-31 | $20.64M 10-K · filed 2018-03-09 | $25.75M derived: sum of 2 quarters · filed 2018-03-09 | $31.94M derived: sum of 3 quarters · filed 2018-08-02 | $38.15M 10-K · filed 2018-03-09 |
| 2017-09-30 | $5.11M 10-K · filed 2018-03-09 | $11.30M derived: sum of 2 quarters · filed 2018-08-02 | $17.52M 10-Q · filed 2017-11-02 | $23.73M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-06-30 | $6.20M 10-Q · filed 2018-08-02 | $12.41M 10-Q · filed 2018-08-02 | $18.63M derived: sum of 3 quarters · filed 2018-08-02 | $24.55M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $6.21M 10-Q · filed 2018-05-08 | $12.43M derived: sum of 2 quarters · filed 2018-05-08 | $18.35M derived: sum of 3 quarters · filed 2018-05-08 | $25.02M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $6.22M 10-K · filed 2018-03-09 | $12.14M derived: sum of 2 quarters · filed 2018-03-09 | $18.80M derived: sum of 3 quarters · filed 2018-03-09 | $25.15M 10-K · filed 2018-03-09 |
| 2016-09-30 | $5.92M 10-K · filed 2018-03-09 | $12.58M derived: sum of 2 quarters · filed 2018-03-09 | $18.93M 10-Q · filed 2017-11-02 | $25.77M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $6.67M 10-K · filed 2018-03-09 | $13.02M 10-Q · filed 2017-08-02 | $19.85M derived: sum of 3 quarters · filed 2018-03-09 | $24.54M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $6.35M 10-K · filed 2018-03-09 | $13.19M derived: sum of 2 quarters · filed 2018-03-09 | $17.88M derived: sum of 3 quarters · filed 2018-03-09 | $22.56M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $6.84M 10-K · filed 2017-03-09 | $11.53M derived: sum of 2 quarters · filed 2017-03-09 | $16.21M derived: sum of 3 quarters · filed 2017-03-09 | $25.90M 10-K · filed 2018-03-09 |
| 2015-09-30 | $4.69M 10-K · filed 2017-03-09 | $9.37M derived: sum of 2 quarters · filed 2017-03-09 | $19.06M 10-Q · filed 2016-11-01 | $27.57M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $4.69M 10-K · filed 2017-03-09 | $14.37M 10-Q · filed 2016-08-09 | $22.89M derived: sum of 3 quarters · filed 2017-03-09 | $41.90M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $9.69M 10-K · filed 2017-03-09 | $18.20M derived: sum of 2 quarters · filed 2017-03-09 | $37.22M derived: sum of 3 quarters · filed 2017-03-09 | $43.23M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $8.51M 10-K · filed 2016-03-10 | $27.53M derived: sum of 2 quarters · filed 2016-03-10 | $33.54M derived: sum of 3 quarters · filed 2016-03-10 | $39.56M 10-K · filed 2017-03-09 |
| 2014-09-30 | $19.02M 10-K · filed 2016-03-10 | $25.03M derived: sum of 2 quarters · filed 2016-03-10 | $31.04M 10-Q · filed 2014-11-04 | $50.03M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $6.01M 10-K · filed 2016-03-10 | $12.03M 10-Q · filed 2014-08-07 | $31.01M derived: sum of 3 quarters · filed 2016-03-10 | $43.95M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $6.01M 10-K · filed 2016-03-10 | $25.00M derived: sum of 2 quarters · filed 2016-03-10 | $37.93M derived: sum of 3 quarters · filed 2016-03-10 | $40.86M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $18.98M 10-K · filed 2015-03-12 | $31.91M derived: sum of 2 quarters · filed 2015-03-12 | $34.85M derived: sum of 3 quarters · filed 2015-03-12 | $37.78M 10-K · filed 2016-03-10 |
| 2013-09-30 | $12.93M 10-K · filed 2015-03-12 | $15.86M derived: sum of 2 quarters · filed 2015-03-12 | $18.80M 10-Q · filed 2014-11-04 | $25.73M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $2.93M 10-K · filed 2015-03-12 | $5.86M 10-Q · filed 2014-08-07 | $12.79M derived: sum of 3 quarters · filed 2015-03-12 | $20.54M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $2.93M 10-K · filed 2015-03-12 | $9.86M derived: sum of 2 quarters · filed 2015-03-12 | $17.61M derived: sum of 3 quarters · filed 2015-03-12 | $25.10M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $6.93M 10-K · filed 2014-03-18 | $14.67M derived: sum of 2 quarters · filed 2014-03-18 | $22.17M derived: sum of 3 quarters · filed 2014-03-18 | $24.68M 10-K · filed 2015-03-12 |
| 2012-09-30 | $7.74M 10-K · filed 2014-03-18 | $15.24M derived: sum of 2 quarters · filed 2014-03-18 | $17.75M 10-Q · filed 2013-11-13 | |
| 2012-06-30 | $7.49M 10-K · filed 2014-03-18 | $10.01M 10-Q · filed 2013-09-03 | ||
| 2012-03-31 | $2.52M 10-K · filed 2014-03-18 | |||
| 2011-12-31 | $31.41M 10-K · filed 2014-03-18 |